Luken Investment Analytics’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$121K Sell
700
-3
-0.4% -$615 0.05% 67
2025
Q4
$180K Buy
703
+3
+0.4% +$786 0.07% 55
2025
Q3
$182K Hold
700
0.07% 55
2025
Q2
$171K Hold
700
0.08% 55
2025
Q1
$185K Hold
700
0.09% 49
2024
Q4
$178K Hold
700
0.08% 48
2024
Q3
$222K Hold
700
0.1% 46
2024
Q2
$262K Hold
700
0.13% 45
2024
Q1
$243K Hold
700
0.12% 43
2023
Q4
$320K Hold
700
0.17% 39
2023
Q3
$341K Hold
700
0.2% 36
2023
Q2
$313K Hold
700
0.18% 36
2023
Q1
$340K Hold
700
0.2% 30
2022
Q4
$359K Buy
+700
New +$368K 0.23% 30
2020
Q4
$287K Buy
+700
New +$291K 0.21% 27

Other funds holding HUM

Luken Investment Analytics's HUM Position: Q1 2026 in Review

Luken Investment Analytics reduced its Humana (HUM) stake by 0.43% in Q1 2026, selling an estimated $615 and leaving 700 shares worth $121K. The position accounts for 0.05% of the portfolio, ranked #67.

Luken Investment Analytics first reported a position in HUM in Q4 2020 and has held it in 15 quarters since. The position peaked at $359K in Q4 2022. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Luken Investment Analytics held 700 shares of Humana worth $121K as of Q1 2026.
  • Luken Investment Analytics sold 3 Humana shares in Q1 2026, an estimated $615.
  • Humana made up 0.05% of Luken Investment Analytics's portfolio in Q1 2026, its #67 holding.
  • Luken Investment Analytics first reported a position in Humana in Q4 2020 and has held it in 15 quarters since.
  • Luken Investment Analytics's Humana position peaked at $359K in Q4 2022.
  • 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Luken Investment Analytics's 13F filing for Q1 2026, filed 12 May 2026.